Key Highlights

  • Adient (NYSE:ADNT) moved to a fiscal fourth-quarter GAAP loss of USD 47 million, or USD 0.62 a share, compared with USD 18 million of profit, or USD 0.22, in the prior-year period.
  • Adjusted diluted EPS stayed at USD 0.52 even as adjusted Net Income eased to USD 40 million from USD 42 million; this non-GAAP figure leaves out restructuring and Debt charges.
  • Top-line sales came in at USD 3.73 billion, versus USD 3.69 billion, while adjusted EBITDA of USD 229 million (USD 226 million a year ago) kept the Margin at 6.1%.
  • For fiscal 2026, free Cash Flow reached USD 222 million (USD 204 million previously), with net Leverage at 1.66 times, up from 1.63 times.

Restructuring and Debt Charges Push Results Into Loss

Adient (NYSE:ADNT), an automotive seating supplier, released its fiscal fourth-quarter and full-year figures, covering the period to September 30, 2026, on November 4, 2026. Restructuring and Impairment outlays rose to USD 74 million from USD 11 million, and SG&A climbed to USD 151 million from USD 124 million. Earnings before interest and taxes fell to USD 44 million from USD 120 million, with net financing charges of USD 62 million. Those financing charges included USD 10 million of premium paid on debt repurchases, a USD 3 million write-off of financing costs and USD 2 million in Loan modification fees, arising after USD 500 million of new long-term debt was issued and USD 549 million repaid. A USD 16 million pension gain softened the blow.

Asia Strength Contrasts With a Thinner Americas Margin

Regional adjusted EBITDA moved in opposite directions. Asia produced USD 136 million, a 17.3% margin, versus USD 106 million and 13.5% previously, with sales of USD 785 million. Americas sales of USD 1.92 billion produced adjusted EBITDA of USD 85 million, down from USD 111 million, equal to a 4.4% margin against 6.2%. In EMEA, sales shrank to USD 1.05 billion from USD 1.15 billion, but adjusted EBITDA nudged up to USD 32 million, a 3.0% margin. Equity income grew to USD 20 million from USD 8 million, and the release offers no reasons for the regional swings. Fiscal 2026 net sales rose 4.4% to USD 15.17 billion (calculated), while adjusted EBITDA of USD 884 million represented a 5.8% margin, down from 6.1%.

Cash Generation, Share Repurchases and the Leverage Ratio

Fourth-quarter free cash flow, meaning Operating Cash Flow minus Capital spending, was USD 61 million versus USD 134 million, since capex rose to USD 106 million from USD 79 million. Fiscal 2026 free cash flow of USD 222 million came before USD 92 million paid to noncontrolling interests. Buybacks totaled USD 45 million in the quarter and USD 100 million for the year, which cut period-end shares to 74.8 million from 79.2 million. Cash stood at USD 886 million, total debt at USD 2.35 billion and net debt at USD 1.47 billion. The fiscal GAAP loss was USD 0.22 a share, adjusted earnings were USD 1.87 versus USD 1.93, and no outlook was offered.

Where Things Stand

Yes, mostly. One-time items drove the GAAP shortfall: restructuring, debt repurchase costs and heavier administrative spending pushed Adient (NYSE:ADNT) to a USD 0.62 loss per share, though steady operations kept adjusted EPS at USD 0.52, equal to last year. Adjusted measures omit restructuring costs that hit the prior year too, so reviewing both views is useful. Watch Americas margins, restructuring cash outlays, capital spending and further buybacks. The provided material offers no fiscal 2027 guidance.